Advertisement
Advertisement

MNKD

MNKD logo

Mannkind Corporation

2.74
USD
Sponsored
+0.04
+1.48%
Apr 22, 15:58 UTC -4
Closed
exchange

After-Market

2.73

-0.01
-0.18%

MNKD Earnings Reports

Positive Surprise Ratio

MNKD beat 18 of 41 last estimates.

44%

Next Report

Date of Next Report
May 13, 2026
Estimate for Q1 26 (Revenue/ EPS)
$109.51M
/
$0.00
Implied change from Q4 25 (Revenue/ EPS)
-2.18%
/
-100.00%
Implied change from Q1 25 (Revenue/ EPS)
+39.76%
/
-100.00%

Mannkind Corporation earnings per share and revenue

On Feb 26, 2026, MNKD reported earnings of -0.05 USD per share (EPS) for Q4 25, missing the estimate of 0.01 USD, resulting in a -440.14% surprise. Revenue reached 111.95 million, compared to an expected 99.56 million, with a 12.45% difference. The market reacted with a -7.43% price change (close before vs. close after earnings).
Looking ahead to Q1 26, 6 analysts forecast an EPS of 0.00 USD, with revenue projected to reach 109.51 million USD, implying an decrease of -100.00% EPS, and decrease of -2.18% in Revenue from the last quarter.

Industry Peers’ Earnings

Industry Peers' Earnings displays EPS earnings data from companies in the same industry. Click on a card to view more details.

logo
Nurix Therapeutics, Inc. Common stock
Report Date
Apr 08, 2026 For Q1 26
Estimate
-$0.76
Actual
-$0.79
Surprise
-2.68%
logo
KALA BIO, Inc. Common Stock
Report Date
Apr 15, 2026 For Q4 25
Estimate
-$1.46
Actual
-$0.67
Surprise
+54.38%
logo
Scilex Holding Company Common Stock
Report Date
Apr 10, 2026 For Q4 25
Estimate
-$0.47
Actual
-$2.21
Surprise
-360.99%
logo
Lexaria Bioscience Corp. Common Stock
Report Date
Apr 13, 2026 For Q2 26
Estimate
-$0.09
Actual
-$0.06
Surprise
+38.08%
logo
Quince Therapeutics, Inc. Common Stock
Report Date
Apr 10, 2026 For Q4 25
Estimate
-$1.92
Actual
-$7.10
Surprise
-268.68%
logo
GeoVax Labs, Inc. New
Report Date
Apr 15, 2026 For Q4 25
Estimate
-$6.29
Actual
$0.00
Surprise
+99.92%
FAQ
For Q4 2025, Mannkind Corporation reported EPS of -$0.05, missing estimates by -440.14%, and revenue of $111.95M, 12.45% above expectations.
The stock price moved down -7.43%, changed from $3.50 before the earnings release to $3.24 the day after.
The next earning report is scheduled for May 13, 2026.
Based on 6 analysts, Mannkind Corporation is expected to report EPS of -- and revenue of $109.51M for Q1 2026.
Check FXEmpire's Earnings Calendar for today's list of reporting companies.
Advertisement